<DOC>
	<DOCNO>NCT02241434</DOCNO>
	<brief_summary>The purpose study study effect stem cell therapy patient Duchenne Muscular Dystrophy .</brief_summary>
	<brief_title>Stem Cell Therapy Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>age group 325 year Duchenne muscular dystrophy diagnose basis clinical presentation presence respiratory distress presence acute infection Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus malignancy acute medical condition respiratory infection , fever , hemoglobin le 8 , bleed tendency , bone marrow disorder , leave ventricular ejection fraction &lt; 30 % pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Duchenne muscular dystrophy</keyword>
	<keyword>Autologous Bone marrow Mononuclear cell therapy</keyword>
	<keyword>Stem Cells</keyword>
</DOC>